Last updated 16 days ago

A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

428 patients around the world
Available in Spain, United States
Hoffmann-La Roche
6Research sites
428Patients around the world
This study is for people with
Nephropathy
Iga nephropathy
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Sanatorio Allende (Nueva Córdoba)
Recruiting
Hipolito Yrigoyen 384, Córdoba
Instituto Médico de la Fundación Estudios Clínicos - Rosario
Recruiting
Italia 428, Rosario - Santa Fe
Santa Casa de Misericórdia de Belo Horizonte
Recruiting
Avenida Francisco Sales, 1111 - 1º Andar - Pesquisa Clínica - Santa Efigênia - Belo Horizonte/MG - CEP 30150-221
Freire Pesquisa Clínica
Recruiting
R. Piauí, 361 - 4º andar - Santa Efigênia, Belo Horizonte - MG, 30150-320, Brazil
Hospital de Clínicas de Porto Alegre - HCPA/UFRGS
Recruiting
Rua Ramiro Barcelos, 2350, Av. Protásio Alves, 211 - Santa Cecília, Porto Alegre - RS, 90035-903
Hospital das Clínicas da Faculdade de Medicina da São Paulo - USP
Recruiting
Rua Dr. Ovídio Pires de Campos 785 - Estado de São Paulo 05403-000
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy